chrX-151955045-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_004961.4(GABRE):c.1177C>T(p.Arg393Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000999 in 1,200,849 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000036 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.0000073 ( 0 hom. 1 hem. )
Consequence
GABRE
NM_004961.4 missense
NM_004961.4 missense
Scores
1
6
10
Clinical Significance
Conservation
PhyloP100: 0.294
Genes affected
GABRE (HGNC:4085): (gamma-aminobutyric acid type A receptor subunit epsilon) The product of this gene belongs to the ligand-gated ionic channel (TC 1.A.9) family. It encodes the gamma-aminobutyric acid (GABA) A receptor which is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. This gene encodes an epsilon subunit. It is mapped to chromosome Xq28 in a cluster comprised of genes encoding alpha 3, beta 4 and theta subunits of the same receptor. Alternatively spliced transcript variants have been identified, but only one is thought to encode a protein. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRE | NM_004961.4 | c.1177C>T | p.Arg393Cys | missense_variant | 9/9 | ENST00000370328.4 | NP_004952.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRE | ENST00000370328.4 | c.1177C>T | p.Arg393Cys | missense_variant | 9/9 | 1 | NM_004961.4 | ENSP00000359353 | P1 | |
GABRE | ENST00000486255.1 | n.4256C>T | non_coding_transcript_exon_variant | 3/3 | 1 | |||||
GABRE | ENST00000483564.5 | n.827C>T | non_coding_transcript_exon_variant | 4/4 | 3 | |||||
GABRE | ENST00000495862.1 | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000357 AC: 4AN: 111899Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34063
GnomAD3 genomes
AF:
AC:
4
AN:
111899
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34063
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000735 AC: 8AN: 1088950Hom.: 0 Cov.: 32 AF XY: 0.00000281 AC XY: 1AN XY: 355490
GnomAD4 exome
AF:
AC:
8
AN:
1088950
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
355490
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000357 AC: 4AN: 111899Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34063
GnomAD4 genome
AF:
AC:
4
AN:
111899
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34063
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
GABRE-related epilepsy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jan 07, 2022 | The maternally inherited hemizygous c.1177C>T (p.Arg393Cys) missense variant identified in the GABRE gene has not been reported in affected individuals in the literature. The variant has 0.00003575 allele frequency in the gnomAD(v3) database (4 out of 111899 heterozygous alleles, no homozygote or hemizygote) suggesting it is not a common benign variant in the populations represented in that database. The variant is located within the predicted neurotransmitter-gated ion-channel transmembrane region [2] and affects a moderately conserved residue. In silico tools provide conflicting predictions about potential pathogenicity of this variant (CADD score = 21.8, REVEL score = 0.322). Due to the lack of compelling evidence for this variant’s pathogenicity and because the disease-gene association is not yet fully established, the maternally inherited hemizygous c.1177C>T (p.Arg393Cys) missense variant identified in the GABRE gene is reported as a Variant of Uncertain Significance in a Gene of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
T
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Uncertain
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
D
Vest4
MutPred
Loss of methylation at R393 (P = 0.0442);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at